The following table or figure may be downloaded to PowerPoint for personal use in teaching and presentations. This feature is available to all subscribers to the journal.
You MUST read and follow the guidelines at Request to Reproduce AJR Content if you are distributing or using AJR content beyond academic use (limited distribution, non-revenue producing, or educational purposes).
(Downloading may take up to 30 seconds.
If the slide opens in your browser, select File -> Save As to save it.)
Click on image to view larger version.
Fig. 6C —64-year-old man with metastatic renal cell carcinoma. Color blood
flow functional maps corresponding to A and B. Blood flow in
right hilar metastatic lesion (arrow) decreased from 353.34
mL/min/100 g before thalidomide treatment (C) to 95.016 mL/min/100 g 12
weeks after treatment (D). Disease remained stable for > 2 years;
patient continued in study for 759 days.
